Literature DB >> 7925457

A new structural transition of serum albumin dependent on the state of Cys34. Detection by 1H-NMR spectroscopy.

J Christodoulou1, P J Sadler, A Tucker.   

Abstract

1. Reactions of fatty-acid-free bovine serum albumin and recombinant human albumin with a range of antiarthritic gold(I) complexes [auranofin, deacetylated auranofin, triethylphosphinegold(I) chloride] and related thiols (thioglucose, tetraacetylthioglucose, glutathione, dithiothreitol) have been investigated using 1H-NMR spectroscopy. 2. In reactions of albumin with auranofin, tetraacetylthioglucose and dithiothreitol, release of cystine was detected, whereas for deacetylated auranofin, thioglucose and glutathione, mixed disulphides with cysteine were produced. It has been previously proposed that Cys34 of human and bovine serum albumins is partly blocked by disulphide formation with cysteine and glutathione. The above reactions lead to deblocking by thiol-disulphide interchange reactions. No release of glutathione from albumin was detected. 3. Changes in the His H epsilon 1 regions of the 1H-NMR spectra show that albumin exists in two structural forms dependent on whether the side-chain of Cys34 is a free thiolate, or blocked by gold(I)triethylphosphine, by disulphide formation with cysteine or by another form of oxidation. We propose that Cys34 is either in a buried or in an exposed environment; the possible molecular basis of the structural change is discussed. 4. The relationship between reactions at Cys34, cysteine release, and the observed structural transition are discussed in terms of chrysotherapy, albumin metabolism and the use of gold(I) as a heavy atom derivative in X-ray crystallographic studies of albumins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7925457     DOI: 10.1111/j.1432-1033.1994.00363.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  Pre-association of polynuclear platinum anticancer agents on a protein, human serum albumin. Implications for drug design.

Authors:  Eva I Montero; Brad T Benedetti; John B Mangrum; Michael J Oehlsen; Yun Qu; Nicholas P Farrell
Journal:  Dalton Trans       Date:  2007-10-02       Impact factor: 4.390

Review 2.  Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties.

Authors:  K Oettl; R E Stauber
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

3.  Antioxidant capacity and structural changes of human serum albumin from patients in advanced stages of diabetic nephropathy and the effect of the dialysis.

Authors:  Marisol Rosas-Díaz; Menandro Camarillo-Cadena; Andrés Hernández-Arana; Eva Ramón-Gallegos; Rafael Medina-Navarro
Journal:  Mol Cell Biochem       Date:  2015-03-11       Impact factor: 3.396

Review 4.  The thiol pool in human plasma: the central contribution of albumin to redox processes.

Authors:  Lucía Turell; Rafael Radi; Beatriz Alvarez
Journal:  Free Radic Biol Med       Date:  2013-06-07       Impact factor: 7.376

Review 5.  Molecular targeting of proteins by L-homocysteine: mechanistic implications for vascular disease.

Authors:  Alla V Glushchenko; Donald W Jacobsen
Journal:  Antioxid Redox Signal       Date:  2007-11       Impact factor: 8.401

6.  Protein metalation by metal-based drugs: reactions of cytotoxic gold compounds with cytochrome c and lysozyme.

Authors:  Chiara Gabbiani; Lara Massai; Federica Scaletti; Elena Michelucci; Laura Maiore; Maria Agostina Cinellu; Luigi Messori
Journal:  J Biol Inorg Chem       Date:  2012-11-07       Impact factor: 3.358

7.  Structure, properties, and engineering of the major zinc binding site on human albumin.

Authors:  Claudia A Blindauer; Ian Harvey; Kerry E Bunyan; Alan J Stewart; Darrell Sleep; David J Harrison; Stephen Berezenko; Peter J Sadler
Journal:  J Biol Chem       Date:  2009-06-11       Impact factor: 5.157

Review 8.  Metal- and Semimetal-Containing Inhibitors of Thioredoxin Reductase as Anticancer Agents.

Authors:  Valentina Gandin; Aristi P Fernandes
Journal:  Molecules       Date:  2015-07-14       Impact factor: 4.411

9.  Circulatory zinc transport is controlled by distinct interdomain sites on mammalian albumins.

Authors:  Katarzyna B Handing; Ivan G Shabalin; Omar Kassaar; Siavash Khazaipoul; Claudia A Blindauer; Alan J Stewart; Maksymilian Chruszcz; Wladek Minor
Journal:  Chem Sci       Date:  2016-08-15       Impact factor: 9.825

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.